Institut Paoli-calmettes

This study is testing whether patients with acute myeloid leukemia (AML) who have responded well to venetoclax-azacitidine treatment can safely stop taking these drugs after 12 months while maintaining their remission. The trial will closely monitor 50 patients who stop treatment…

This is the first human study testing a new drug called IPH5301 for people with advanced cancers that have spread. The trial has two parts: first finding the safest dose of IPH5301 alone, then testing it combined with standard chemotherapy in breast cancer patients. It's for adul…

This study tests whether the drug DASATINIB can help adults with acute myeloid leukemia when standard treatments have failed. Researchers will give 35 participants DASATINIB for up to 3 months and monitor their blood and bone marrow response. The goal is to see if this approach c…

This study is testing whether removing the kidney after successful immunotherapy treatment can help control metastatic kidney cancer long-term. Researchers want to see if patients who have surgery and then stop immunotherapy can stay cancer-free as well as those who continue taki…